propranolol has been researched along with 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4h-pyran-3-yl 4-nitrobenzoate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chang, L; Chang, SJ; Chen, J; Chen, Q; Chen, Z; Lin, X; Qiu, Y; Ying, H; Yu, Z | 1 |
1 other study(ies) available for propranolol and 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4h-pyran-3-yl 4-nitrobenzoate
Article | Year |
---|---|
Apelin Receptor Can Act as a Specific Marker and Promising Therapeutic Target for Infantile Hemangioma.
Topics: Animals; Apelin Receptors; Cell Proliferation; Endothelial Cells; Hemangioma; Humans; Mice; Propranolol | 2023 |